Chief, Clinical Studies Unit, LCID
The Clinical Studies Unit was created in 1997. Its main objective is the development and conduct of clinical research in areas of interest to the Laboratory of Clinical Infectious Diseases and its senior staff. Clinical projects are underway that complement molecular studies.
Siu-Ping Turk, R.N.Carla Williams, R.N.Jennifer Cirner, C.R.N.P.
Cohen JI, Jaffe ES, Dale JK, Pittaluga S, Heslop HE, Rooney CM, Gottschalk S, Bollard CM, Rao VK, Marques A, Burbelo PD, Turk SP, Fulton R, Wayne AS, Little RF, Cairo MS, El-Mallawany NK, Fowler D, Sportes C, Bishop MR, Wilson W, Straus SE. Characterization and treatment of chronic active Epstein-Barr virus disease: a 28 year experience in the United States. Blood. 2011 Jun 2;117(22):5835-49.
Marques AR. Lyme disease: a review. Curr Allergy Asthma Rep. 2010 Jan;10(1):13-20.
Burbelo PD, Issa AT, Ching KH, Cohen JI, Iadarola MJ, Marques A. Rapid, simple, quantitative, and highly sensitive antibody detection for lyme disease. Clin Vaccine Immunol. 2010 Jun;17(6):904-9.
Marques A. Chronic lyme disease: a review. Infect Dis Clin North Am. 2008 Jun;22(2):341-60.
Londoño D, Marques A, Hornung RL, Cadavid D. IL-10 helps control pathogen load during high-level bacteremia. J Immunol. 2008 Aug 1;181(3):2076-83.
Visit PubMed for a complete publication listing.
back to top
Last Updated July 10, 2013
Last Reviewed July 10, 2013